In the same year, Kang H. J. et al. reported that also HER2 interacts with NRF2 to promote the transcription of antioxidant and detoxification genes and that this partnership confers drug resistance to human breast cancer cells [27]. The gene discussed is ERBB2; the disease is breast carcinoma.